How does metformin reduce blood sugar
Pro Research Analysisby 
Searched over 200M research papers
How Metformin Reduces Blood Sugar
Metformin is a widely-used medication for managing type 2 diabetes mellitus (T2DM). Despite its long history and extensive use, the precise mechanisms by which it lowers blood sugar are complex and multifaceted. This article synthesizes current research to elucidate how metformin achieves its glucose-lowering effects.
Inhibition of Hepatic Glucose Production
One of the primary mechanisms by which metformin reduces blood sugar is by inhibiting hepatic glucose production (HGP). Metformin achieves this by suppressing gluconeogenesis, the process by which the liver produces glucose from non-carbohydrate sources. This suppression is primarily due to the inhibition of hepatic glycogenolysis, the breakdown of glycogen into glucose 126. Studies have shown that metformin significantly reduces fasting plasma glucose and hemoglobin A1c levels by decreasing basal HGP .
Activation of AMP-Activated Protein Kinase (AMPK)
Metformin activates AMP-activated protein kinase (AMPK), a key regulatory enzyme in cellular energy homeostasis. AMPK activation leads to reduced hepatic glucose production and increased insulin sensitivity. This mechanism is crucial for the drug's effectiveness in lowering blood sugar levels 26. However, recent studies suggest that metformin's effects are not solely dependent on AMPK activation, indicating the involvement of other pathways .
Impact on the Gut and Gut-Brain-Liver Axis
Emerging evidence highlights the role of the gut in metformin's glucose-lowering effects. Metformin alters the gut microbiome, increasing the abundance of beneficial bacteria and reducing harmful ones like Megamonas and Klebsiella, which are positively correlated with blood glucose levels 78. Additionally, metformin increases the secretion of glucagon-like peptide-1 (GLP-1), an incretin hormone that enhances insulin secretion and inhibits glucagon release, thereby lowering blood glucose levels 69.
Enhancement of Aerobic Glycolysis
In well-controlled T2DM patients, metformin reduces fasting glycemia by promoting aerobic glycolysis, independent of decreasing endogenous glucose production. This process involves increased peripheral glucose clearance and lactate production, which is consistent with metformin-induced inhibition of mitochondrial electron transport chain activity .
Modulation of Bile Acids
Metformin also affects bile acid metabolism, which plays a role in glucose homeostasis. By reducing intestinal bile acid resorption, metformin increases the intraluminal concentration of bile acids, which in turn stimulates GLP-1 secretion and modulates gut microbiota composition. This mechanism contributes to the drug's glucose-lowering effects .
Conclusion
Metformin lowers blood sugar through a combination of mechanisms, including the inhibition of hepatic glucose production, activation of AMPK, modulation of the gut microbiome, enhancement of aerobic glycolysis, and alteration of bile acid metabolism. These multifaceted actions make metformin a highly effective and widely-used treatment for type 2 diabetes. Further research is needed to fully understand the complex interplay of these mechanisms and to optimize the therapeutic use of metformin.
Sources and full results
Most relevant research papers on this topic